HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.

Abstract
Six platinum(IV) compounds derived from an oxaliplatin analogue containing the unsaturated cyclic diamine trans-1,2-diamino-4-cyclohexene (DACHEX), in place of the 1,2-diaminocyclohexane, and a range of axial ligands, were synthesized and characterized. The derivatives with at least one axial chlorido ligand demonstrated solvent-assisted photoreduction. The electrochemical redox behavior was investigated by cyclic voltammetry; all compounds showed reduction potentials suitable for activation in vivo. X-ray photoelectron spectroscopy (XPS) data indicated an X-ray-induced surface reduction of the Pt(IV) substrates, which correlates with the reduction potentials measured by cyclic voltammetry. The cytotoxic activity was assessed in vitro on a panel of human cancer cell lines, also including oxaliplatin-resistant cancer cells, and compared with that of the reference compounds cisplatin and oxaliplatin; all IC50 values were remarkably lower than those elicited by cisplatin and somewhat lower than those of oxaliplatin. Compared to the other Pt(IV) compounds of the series, the bis-benzoate derivative was by far (5-8 times) the most cytotoxic showing that low reduction potential and high lipophilicity are essential for good cytotoxicity. Interestingly, all the complexes proved to be more active than cisplatin and oxaliplatin even in three-dimensional spheroids of A431 human cervical cancer cells.
AuthorsParide Papadia, Katia Micoli, Alessandra Barbanente, Nicoletta Ditaranto, James D Hoeschele, Giovanni Natile, Cristina Marzano, Valentina Gandin, Nicola Margiotta
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 7 (Mar 27 2020) ISSN: 1422-0067 [Electronic] Switzerland
PMID32230896 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cyclohexenes
  • Ligands
  • Organoplatinum Compounds
  • Prodrugs
  • Oxaliplatin
  • Cisplatin
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Line, Tumor
  • Cisplatin (chemistry, pharmacology)
  • Cyclohexenes (chemical synthesis, chemistry)
  • Drug Resistance, Neoplasm
  • Drug Screening Assays, Antitumor
  • Humans
  • Ligands
  • Neoplasms (drug therapy)
  • Organoplatinum Compounds (chemical synthesis, chemistry, pharmacology)
  • Oxaliplatin (analogs & derivatives, chemistry, pharmacology)
  • Prodrugs (chemical synthesis, chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: